PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.14%
Revenue growth at 50-75% of QCOM's 18.31%. Martin Whitman would worry about competitiveness or product relevance.
13.66%
Gross profit growth 1.25-1.5x QCOM's 10.66%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
17.15%
EBIT growth above 1.5x QCOM's 4.88%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
17.15%
Operating income growth above 1.5x QCOM's 4.88%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
20.87%
Net income growth above 1.5x QCOM's 1.69%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
20.00%
EPS growth of 20.00% while QCOM is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
20.00%
Diluted EPS growth of 20.00% while QCOM is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
0.82%
Share reduction more than 1.5x QCOM's 1.69%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
1.33%
Diluted share count expanding well above QCOM's 1.69%. Michael Burry would fear significant dilution to existing owners' stakes.
-0.82%
Dividend reduction while QCOM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
68.24%
OCF growth under 50% of QCOM's 198.25%. Michael Burry might suspect questionable revenue recognition or rising costs.
830.00%
FCF growth above 1.5x QCOM's 54.66%. David Dodd would verify if the firm’s strategic investments yield superior returns.
110.16%
10Y revenue/share CAGR under 50% of QCOM's 739.48%. Michael Burry would suspect a lasting competitive disadvantage.
77.19%
5Y revenue/share CAGR under 50% of QCOM's 739.48%. Michael Burry would suspect a significant competitive gap or product weakness.
45.91%
3Y revenue/share CAGR under 50% of QCOM's 273.91%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
164.73%
OCF/share CAGR of 164.73% while QCOM is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
147.97%
3Y OCF/share CAGR at 50-75% of QCOM's 240.98%. Martin Whitman would suspect weaker recent execution or product competitiveness.
1724.99%
10Y net income/share CAGR of 1724.99% while QCOM is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
2101.73%
Net income/share CAGR of 2101.73% while QCOM is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
224.85%
Below 50% of QCOM's 647.55%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
25.90%
Equity/share CAGR of 25.90% while QCOM is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
53.12%
Below 50% of QCOM's 352.50%. Michael Burry suspects a serious short-term disadvantage in building book value.
47.43%
Dividend/share CAGR of 47.43% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-16.51%
Negative 5Y dividend/share CAGR while QCOM stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-22.60%
Negative near-term dividend growth while QCOM invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
16.65%
AR growth well above QCOM's 15.46%. Michael Burry fears inflated revenue or higher default risk in the near future.
7.20%
We show growth while QCOM is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
7.28%
Asset growth 1.25-1.5x QCOM's 4.91%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
7.82%
BV/share growth above 1.5x QCOM's 1.77%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.24%
Debt shrinking faster vs. QCOM's 2.46%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
0.94%
R&D growth drastically higher vs. QCOM's 1.14%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
17.41%
SG&A growth well above QCOM's 24.48%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.